Keap1-Nrf2-IN-9 is a potent inhibitor of Keap1-Nrf2 protein-protein interaction (PPI) with an IC50 value of 0.575 µM; it upregulates the expression of Nrf2 target genes, including heme oxygenase 1 (Hmox1), glutathione S-transferase P (GstP), and the catalytic (Gclc) and regulatory (Gclm) subunits of glutamate-cysteine ligase; it exhibits no cytotoxic activity in ARPE19 cells.